Michael Singer's most recent trade in Cartesian Therapeutics Inc was a trade of 7,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics Inc | Michael Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,600 | 73,533 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Singer Michael | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Dec 2024 | 20,000 | 70,933 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2024 | 28,821 | 90,933 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 377,208 | 383,796 (0%) | 0% | - | Common Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 110,151 | 119,754 (0%) | 0% | - | Common Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 94,568 | 96,219 (0%) | 0% | - | Common Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 94,568 | 96,219 (0%) | 0% | - | Common Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 55,746 | 56,719 (0%) | 0% | - | Common Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 14,535 | 14,788 (0%) | 0% | - | Common Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 11,316 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 7,005 | 7,127 (0%) | 0% | - | Common Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 3,304 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 2,837 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 2,837 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 1,672 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 436 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Cartesian Therapeutics Inc | Michael Singer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 210 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Selecta Biosciences Inc | Singer Michael | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2023 | 228,000 | 228,000 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Michael Singer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2023 | 178,000 | 288,123 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Michael Singer | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Dec 2023 | 3,000 | 3,304 | - | - | Series A Convertible Preferred Stock |